Calculate your SIP ReturnsExplore
On March 31, 2024, Jubilant Ingrevia Limited informed the stock exchanges that the company had commissioned a new facility for Diketenes and Derivatives.
On Sunday, Jubilant Ingrevia Limited announced the commissioning of a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh.
Currently, the company has more than 134 products and innovative solutions commercialised. Jubilant Ingrevia Limited has more than four decades of experience and has developed proficiency across 35 key chemistry and technology platforms across its businesses, which include nutrition, speciality, and chemical intermediates.
The company stated in an exchange filing that the newly commissioned facility adds an extra capacity of ~2,000 TPA to produce high-value esters.
They said, “This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.”
Jubilant Ingrevia further stated that aligning with its long-term strategic objectives, the company remains committed to the commissioning of future phases of Diketene derivatives. In addition to existing clients, the expanded range of diketene derivatives will be aimed at a new category of customers in key international markets, such as the USA and European regions.
The Chief Executive Officer and Managing Director of Jubilant Ingrevia Limited, Deepak Jain, said, “I am delighted to emphasise our unwavering dedication to the speciality chemicals business with the introduction of this new facility. Diketene and derivatives represent an accelerated growth platform for us. We are committed to cultivating a comprehensive range of advanced product portfolios within this segment with about half a dozen existing derivatives and several new ones in the pipeline.”
He further added that the company’s announcement of a new facility marks an inflexion in growth as this advancement will bring them closer to satisfying their client’s requirements for innovative products and solutions, leveraging a distinctive and specialised chemistry platform.
On April 1, 2024, the Jubilant Ingrevia share price opened at ₹455.00, touching the day’s high at ₹468.65, as of 12:44 PM on the NSE.
Jubilant Ingrevia Limited is a global integrated Life Science product and innovative solutions
provider that serves Nutrition, Pharmaceutical, Agrochemical, Consumer and Industrial customers.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Enjoy Zero Brokerage on Equity Delivery
Join our 2 Cr+ happy customers
Get the link to download the App
